Patents by Inventor Marie Bernard

Marie Bernard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230091047
    Abstract: The present application relates to compounds according to Formula (I), pharmaceutical compositions comprising at least one of said compounds, their use as a medicament, and their use in treating chronic hepatitis B virus (HBV) infection. The disclosure further pertains to methods for preparing compounds according to Formula (I).
    Type: Application
    Filed: March 13, 2020
    Publication date: March 23, 2023
    Inventors: Sandrine Céline GROSSE, Jan Martin BERKE, Meng-yang HSIAO, Lili HU, Edgar JACOBY, Tim Hugo Maria JONCKERS, Bart Rudolf Romanie KESTELEYN, Stefaan Julien LAST, Carlolina MARTINEZ LAMENCA, Mathieu PERRIER, Serge Maria Aloysius PIETERS, Pierre Jean-Marie Bernard RABOISSON, Abdellah TAHRI, Koen VANDYCK, Wim Gaston VERSCHUEREN
  • Publication number: 20230065527
    Abstract: The present disclosure related to compounds that can be useful as inhibitors of PD-1, PD-L1 or the PD-1/PD-L1 interaction. Also disclosed herein are pharmaceutical compositions of that can include a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and uses of or methods of using a compound of Formula (I), or a pharmaceutically acceptable salt thereof, for the treatment of PD-L1 related diseases including but not limited to liver diseases, cancer, hepatocellular carcinoma, viral diseases, or hepatitis B.
    Type: Application
    Filed: August 12, 2021
    Publication date: March 2, 2023
    Inventors: Tongfei Wu, Pierre Jean-Marie Bernard Raboisson, Francois Gonzalvez, Antitsa Dimitrova Stoycheva, Jerome Deval, Cheng Liu, Qingling Zhang
  • Patent number: 11591341
    Abstract: Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: February 28, 2023
    Assignee: Aligos Therapeutics, Inc.
    Inventors: Sandrine Vendeville, Pierre Jean-Marie Bernard Raboisson, Yannick Debing
  • Patent number: 11593691
    Abstract: An information retrieval system (IPS). The system comprises an input interface (IN) for receiving a query related to an object of interest. A concept mapper (CM) is configured to map the query to one or more associated concept entries of a hierarchic graph data structure (ONTO). The entries in said structure encode linguistic descriptors of components of a model (GM) for said object (OB). A metric-mapper (MM) is configured to map the query to one or more metric relationship descriptors. A geo-mapper (GEO) is configured to map said concept entries against the geometric model linked to the hierarchic graph data structure to obtain spatio-numerical data associated with said linguistic descriptors. A metric component (MTC) is configured to compute one or more metric or spatial relationships between said object components based on the spatio-numerical data and the one or more metric relationship descriptors.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: February 28, 2023
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Rolf Jurgen Weese, Alexandra Groth, Tilman Wekel, Vincent Maurice Andre Auvray, Raoul Florent, Romane Isabelle Marie-Bernard Gauriau
  • Publication number: 20230051483
    Abstract: Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 15, 2022
    Publication date: February 16, 2023
    Inventors: Sandrine Vendeville, Pierre Jean-Marie Bernard Raboisson, David McGowan, Yannick Debing
  • Publication number: 20230031213
    Abstract: The present disclosure related to compounds that can be useful as inhibitors of PD-1, PD-L1 or the PD-1/PD-L1 interaction. Also disclosed herein are pharmaceutical compositions of that can include a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and uses of or methods of using a compound of Formula (I), or a pharmaceutically acceptable salt thereof, for the treatment of PD-L1 related diseases including but not limited to liver diseases, cancer, hepatocellular carcinoma, viral diseases, or hepatitis B.
    Type: Application
    Filed: June 15, 2022
    Publication date: February 2, 2023
    Inventors: Tongfei Wu, Pierre Jean-Marie Bernard Raboisson, Francois Gonzalvez, Antitsa Dimitrova Stoycheva, Cheng Liu, Jerome Deval, David McGowan
  • Publication number: 20230014173
    Abstract: The present invention relates to the following compounds wherein the integers are as defined in the description, and where the compounds may be useful as medicaments, for instance for use in the treatment of tuberculosis.
    Type: Application
    Filed: September 17, 2021
    Publication date: January 19, 2023
    Applicant: Janssen Sciences Ireland UC
    Inventors: Jérôme Émile Georges Guillemont, Magali Madeleine Simone Motte, Pierre Jean-Marie Bernard Rabiosson, Abdellah Tahri
  • Publication number: 20230002413
    Abstract: The present disclosure related to compounds that can be useful as inhibitors of PD-1, PD-L1 or the PD-1/PD-L1 interaction. Also disclosed herein are pharmaceutical compositions of that can include a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and uses of or methods of using a compound of Formula (I), or a pharmaceutically acceptable salt thereof, for the treatment of PD-L1 related diseases including but not limited to liver diseases, cancer, hepatocellular carcinoma, viral diseases, or hepatitis B.
    Type: Application
    Filed: May 19, 2021
    Publication date: January 5, 2023
    Inventors: Tongfei Wu, Pierre Jean-Marie Bernard Raboisson, Antitsa Dimitrova Stoycheva, Francois Gonzalvez, Jerome Deval, Cheng Liu
  • Publication number: 20230002409
    Abstract: The present invention relates to macrocyclic pyridotriazine derivatives and the prodrugs thereof, and the pharmaceutically acceptable salts, solvates or polymorph thereof, and the use of such compounds as a medicament, in particular in the prevention and/or treatment of viral infections caused by viruses belonging to the Orthomyxoviridae family. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, and to the compositions or preparations for use as a medicament, more preferably for the prevention or treatment of viral infections caused by viruses belonging to the Orthomyxoviridae family.
    Type: Application
    Filed: March 15, 2022
    Publication date: January 5, 2023
    Inventors: Robert Than HENDRICKS, Antitsa Dimitrova STOYCHEVA, Jean-François BONFANTI, Pierre Jean-Marie Bernard RABOISSON, Jérôme Michel Claude FORTIN, Guillaume Jean Maurice MERCEY
  • Patent number: 11541050
    Abstract: This invention relates to pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections such as HCV or HBV.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: January 3, 2023
    Assignee: JANSSEN SCIENCES IRELAND UC
    Inventors: David Mc Gowan, Pierre Jean-Marie Bernard Raboisson, Werner Embrechts, Tim Hugo Maria Jonckers, Stefaan Julien Last, Serge Maria Aloysius Pieters, Jaromir Vlach
  • Patent number: 11545252
    Abstract: During a medical intervention such as an angiography, the X-ray examination equipment (such as that mounted on a C-arm) produces a very large number of imaging frames of the intervention, as it progresses. This information contains frame sequences which can be effectively used to improve a medical report of the intervention. The sequence will contain sequences which contain similar clinical information though, and these frames may be considered to be redundant and not useful for inclusion in the medical report. The aspects detailed herein enable a selection of non-redundant sequences and/or frames, based on contextual information, obtained from the sequence of images, and/or other medical equipment, during an intervention. In this way, the redundancy inherent in the original frame sequence can be removed, leaving a set of prepared candidate sequences for insertion into a multimedia or documentary medical report.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: January 3, 2023
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Vincent Maurice André Auvray, Romane Isabelle Marie-Bernard Gauriau, Raoul Florent
  • Patent number: 11491157
    Abstract: The invention concerns compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment of respiratory syncytial virus infection. (Formula I).
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: November 8, 2022
    Assignee: Janssen Sciences Ireland Unlimited Company Co Cork, IE
    Inventors: David Francis Alain Lançois, Jérôme Émile Georges Guillemont, Pierre Jean-Marie Bernard Raboisson, Dirk André Emmy Roymans, Peter Rigaux, Antoine Benjamin Michaut
  • Publication number: 20220340522
    Abstract: The present invention concerns substituted indoline derivatives, methods to prevent or treat dengue viral infections by using said compounds and also relates to said compounds for use as a medicine, more preferably for use as a medicine to treat or prevent dengue viral infections. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of dengue viral infections. The invention also relates to processes for preparation of the compounds.
    Type: Application
    Filed: June 16, 2022
    Publication date: October 27, 2022
    Applicants: Janssen Pharmaceuticals, Inc., Katholieke Universiteit Leuven
    Inventors: Jean-François Bonfanti, Bart Rudolf Romanie Kesteleyn, Dorothée Alice Marie-Eve Bardiot, Arnaud Didier M Marchand, Erwin Coesemans, Jérôme Michel Claude Fortin, Guillaume Jean Maurice Mercey, Pierre Jean-Marie Bernard Raboisson
  • Patent number: 11464783
    Abstract: Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: October 11, 2022
    Assignee: Aligos Therapeutics, Inc.
    Inventors: Sandrine Vendeville, Pierre Jean-Marie Bernard Raboisson
  • Patent number: 11409422
    Abstract: The present invention relates to a device for interacting with vessel images, the device (14) comprising: an interface unit (22); a processing unit (20); wherein the interface unit (22) comprises: a display (21); and an input setup (23); wherein the display (21) is configured to display a vessel image (24); wherein the input setup (23) is configured to receive a user input in relation to the vessel image (24); wherein the processing unit (20) is configured to: determine, for at least one vessel (26) in the vessel image (24), a vessel contour (30); determine, from the user input, an identifier position (36) in the vessel image (24); indicate at least a portion (38) of the vessel contour (30) in the vessel image (24), if the determined identifier position (36) is spaced apart from the vessel contour (30) by a distance (37) within a predefined distance range; determine, from the user input, a drag direction (42); and move the indicated portion (38) along the vessel contour (30) based on the determined drag direc
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: August 9, 2022
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Javier Olivan Bescos, Raoul Florent, Romane Isabelle Marie-Bernard Gauriau, Christian Haase, Michael Grass, Vincent Maurice Andre Auvray
  • Patent number: 11408350
    Abstract: Electrical harness for a turbomachine, comprising a first termination connected to an apparatus (3) capable of emitting an electrical signal, and a second termination connected to a signal processing apparatus (4), characterised in that it comprises an electronic circuit for filtering the signal, said circuit comprising at least one electronic component associated with an operating temperature threshold, and one thermally triggered electrical interruption means connected in series or in parallel with said electronic component, said electrical interruption means being capable of changing from an open state in which a current cannot flow through it, to a closed state in which a current can flow through it, or reciprocally from a closed state to an open state, from a tripping temperature lower than or equal to the operating temperature threshold of said electronic component.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: August 9, 2022
    Assignee: SAFRAN AIRCRAFT ENGINES
    Inventors: George Alex Kwakye, Benoit Marie Bernard Kieffer, Jacques Paul Michel Gauvrit, Jean-François Jean-Paul Clément Schielin
  • Patent number: 11407715
    Abstract: The present invention concerns substituted indoline derivatives, methods to prevent or treat dengue viral infections by using said compounds and also relates to said compounds for use as a medicine, more preferably for use as a medicine to treat or prevent dengue viral infections. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of dengue viral infections. The invention also relates to processes for preparation of the compounds.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: August 9, 2022
    Assignees: Janssen Pharmaceuticals, Inc., Katholieke Universiteit Leuven
    Inventors: Jean-François Bonfanti, Bart Rudolf Romanie Kesteleyn, Dorothée Alice Marie-Eve Bardiot, Arnaud Didier M Marchand, Erwin Coesemans, Jérôme Michel Claude Fortin, Guillaume Jean Maurice Mercey, Pierre Jean-Marie Bernard Raboisson
  • Publication number: 20220242879
    Abstract: The application describes fused heterocycle derivative compounds, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection.
    Type: Application
    Filed: May 27, 2020
    Publication date: August 4, 2022
    Inventors: Scott D. KUDUK, Christelle Catherine Cecile DOEBELIN, Abdellah TAHRI, Sandrine Céline GROSSE, Stefaan Julien LAST, Lindsey Graham DERATT, Koen VANDYCK, Pierre Jean-Marie Bernard RABOISSON, Jan Martin BERKE, Wim Gaston VERSCHUEREN, Michel OBRINGER
  • Publication number: 20220235052
    Abstract: The present invention relates to purine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.
    Type: Application
    Filed: August 30, 2021
    Publication date: July 28, 2022
    Inventors: Jean-François BONFANTI, Frédéric Marc Maurice DOUBLET, Werner EMBRECHTS, Jérôme Michel Claude FORTIN, David Craig MC GOWAN, Philippe MULLER, Pierre Jean-Marie Bernard RABOISSON
  • Publication number: 20220186681
    Abstract: An aircraft turbine engine module, including a degassing tube and an ejection cone. The tube and the cone are engageable together by structures which cause them to be centered when engaged together. Also provided is a locating and adjusting tool for assembling the module.
    Type: Application
    Filed: March 2, 2022
    Publication date: June 16, 2022
    Inventor: Samuel Louis-Marie BERNARD